Who is Adele Cheli, GSK's New VP Global Sustainability?

Claire Lund is departing GSK after more than 13 years with the pharmaceutical company, where she has served as Vice President of Sustainability.

Adele Cheli, who most recently held the position of Head of Nature Action and Partnerships at GSK, will take over the role.

Claire's impact on sustainability

Throughout her tenure at GSK, Claire worked across the company's global operations, encompassing medicines, vaccines, R&D and supply chains.

Her focus centred on advancing both planetary and human health mitigation, whilst supporting the sector's adaptation to climate change and nature loss.

Under Claire's leadership, GSK secured A scores from CDP – the highest possible rating – in both Climate and Water categories.

She brings more than 25 years of experience in leading transformational strategic change programmes across energy, facilities, capital and renewables.

Before joining GSK, she worked in the UK Government, where she led Energy procurement programmes.

Claire held the VP Sustainability position at GSK for more than five years, having previously spent eight years as the company's Head of Global Sustainability.

During this time, GSK became the first pharmaceutical company to have nature targets validated by the Science Based Targets Network.

She also contributed to the company's progress in transitioning to low-carbon inhalers and embedding eco-design into all new products between 2019 and 2025.

Claire says on LinkedIn: "After an incredible chapter at GSK, I will soon be taking on a new challenge – more on that to come.

"I'm immensely proud of what we've achieved together. From embedding sustainability into our medicines and vaccines, to accelerating progress on climate and nature and decoupling growth and environmental impact, this has been a true team effort.

"I'm pleased to be handing the baton to Adele Cheli, who will take on the role of Global VP, Sustainability. She brings deep experience and strong strategic leadership and I know GSK will continue to deliver sustainability progress under her leadership.

"While I'm excited for what's next for me, I'll continue to celebrate the impact being made as GSK and the team drive towards a healthier, more sustainable future."

Adele Cheli takes the helm

Adele will succeed Claire in the role, bringing more than 12 years of experience at GSK.

She joined the company in 2013 as an Associate for the Future Leaders Graduate Programme, where her focus was mainly on procurement, with work in brand activation and medical communications.

She subsequently moved into Innovation roles at the company, progressing to become Innovation Manager in 2017, where she negotiated deals to enhance product and digital health innovation.

Adele spent the following years working in strategy, marketing and operations, serving as the Sustainability Partnerships and Strategy Director between 2021 and 2025.

Her most recent position was Head of Nature Action and Partnerships, which she held for just over a year.

Adele assumes the role of Global Vice President of Sustainability at GSK as of March 2026.

She writes on LinkedIn: "Exciting news – I've been appointed Global VP, Sustainability at GSK, leading our work globally to deliver more sustainable medicines and vaccines for patients.

"A huge thanks to Claire Lund, for the leadership and momentum she has built to date.

"I'm looking forward to continuing to drive progress, working with our brilliant teams across GSK and with our partners to deliver against our climate and nature commitments, towards a healthier, more sustainable future."